维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="NICOLINI FE"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	NOD/SCID mice engineered to express human IL-3, GM-CSF and steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration显示文摘	Nicolini FE Cashman JD Hogge DE	2004	Leukemia2004，18，：	1
2	BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors:recommendations from an expert panel on behalf of European Leukemia Net显示文摘	Soverini S Hochhaus A Nicolini FE	2011	{H}Blood2011，，05：	1
3	Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia显示文摘	Preudhomme C Guilhot J Nicolini FE		0，，：	1
4	Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias 显示文摘	Nicolini FE Basak GW Soverini S	2011	Blood2011，118，：	1
5	BMP4 regulation of 0 human megakaryocytic differentiation is involved in thrombopoietin signaling显示文摘	Jeanpierre S Nicolini FE Kaniewski B	2008	Blood2008，112，8：	1
6	History of chronic myeloid leukemia:a paradigm in the treatment of cancer 显示文摘	Gonon - Demoulian R Goldman JM Nicolini FE	2014	Bull Cancer2014，101，1：	1
7	Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML ( Fi (w) -LMC GROUP) 显示文摘	Nicolini FE Corm S Le QH	2006	Leukemia2006，20，6：	1
8	Allogeneic stem cell transplantation for patients harboring T315I BCRABL mutated leukemias显示文摘	Nicolini FE Basak GW Soverini S	2011	Blood2011，118，20：	1
9	Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice显示文摘	Nicolini FE Holyoake TL Cashman JD Chu PP Lambie K Eaves CJ	1999	Blood1999，94，8：	1
10	Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow 显示文摘	Holyoake TL Nicolini FE Eaves CJ	1999	Exp Hematol1999，27，9：	1
11	The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge显示文摘	Nicolini FE Chomel JC Roy L	2010	Clin Lymphoma Myeloma Leuk2010，10，5：	1
12	Expression of a human beta-globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells 显示文摘	Nicolini FE Imren S Oh IH Humphries RK Leboulch P Fabry ME	2002	Blood2002，100，4：	1
13	NOD/SCID mice engineered to express human IL-3,GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration显示文摘	Cashman JD Hogge DE	2004	Leukemia2004，18，2：	1
14	Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias显示文摘	Nicolini FE Basak GW Soverini S		Blood0，，：	1
15	Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients:a retrospective analysis from the French intergroup of CML(Fi(phi)-LMC GROUP)显示文摘	Nicolini FE Corm S Le QH	2006	Leukemia2006，20，6：	1
16	Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia显示文摘	Preudhomme C Guilhot J Nicolini FE		0，，：	1
17	BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet 显示文摘	Soverini S Hochhaus A Nicolini FE	2011	Blood2011，118，5：	1
18	Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia (CML) patients (pts) with stable undetectable Bcr-Abl transcripts:results from the French CML Group (FILMC)[abstract]显示文摘	Rea D Rousselot P Nicolini FE		0，，：	1
19	Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation显示文摘	Nicolini FE Mauro MJ Martinelli G	2009	Blood2009，114，26：	1
20	I matinib plus peginterferon alfa-2a in chronic myeloid leukemia显示文摘	Preudhomme C Guilhot J Nicolini FE		0，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示